Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform t…

Biotechnology

US, Cambridge [HQ]

Summary
IR
Fin. Reports
Financials
Leadership & Strategy
Possible Catalysts

Board & Officers
Business Intelligence
Employee Voice
Mergers and Acquisitions
Qualified Risks
ESG Scores [Soon]

Strategy & Leadership

Mergers & Acquisitions Beta

M&As

FHTX M&As
Biotechnology M&A

M&A Deals · Breakdown

Foghorn Therapeutics Inc. has no acquisition track records yet.

M&A Deals · History

Foghorn Therapeutics Inc. has no acquisition track records yet.